METAVIA: PHASE 1 PART 3 TO INCLUDE WEGOVY EARLY DROP-OUT PATIENTS TO EXPLORE POTENTIAL SUPERIORITY OF DA-1726 ON SAFETY AND TOLERABILITY

Reuters · 2d ago

Please log in to view news